4.3 Review

Evaluating home injection compared with healthcare-setting injection of somatostatin analogs: a systematic literature review

Related references

Note: Only part of the references are listed.
Article Rheumatology

Efficacy of a nurse-led patient education intervention in promoting safety skills of patients with inflammatory arthritis treated with biologics: a multicentre randomised clinical trial

Catherine Beauvais et al.

Summary: Nurse-led patient education can improve safety skills and coping abilities of patients with inflammatory arthritis treated with biologic disease-modifying antirheumatic drugs (bDMARDs). Education has positive effects on vaccination willingness and adherence-related behaviors.

RMD OPEN (2022)

Article Rheumatology

Patient Preference for Treatment Mode of Biologics in Rheumatoid Arthritis: A 2020 Web-based Survey in Japan

Mitsumasa Kishimoto et al.

Summary: This study found that patient preference for bDMARD treatment mode was significantly associated with age, frequency of hospital visits, flexible administration setting, and anxiety or other hurdles to self-injection. Changes in patient background which affect the preferred treatment mode should be considered in decision-making for RA therapy with bDMARDs.

RHEUMATOLOGY AND THERAPY (2021)

Review Medicine, Research & Experimental

Patient and Healthcare Provider Perspectives of First-Generation Somatostatin Analogs in the Management of Neuroendocrine Tumors and Acromegaly: A Systematic Literature Review

David Cella et al.

Summary: Based on a systematic literature review, LAN was favored over OCT in the treatment of acromegaly and NETs, with technical problems and pain during injections being the most influential factors in treatment experience.

ADVANCES IN THERAPY (2021)

Review Medicine, General & Internal

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA statement was designed to help systematic reviewers transparently report the purpose, methods, and findings of their reviews. The updated PRISMA 2020 statement includes new reporting guidance, a 27-item checklist, an abstract checklist, and revised flow diagrams for reviews.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Endocrinology & Metabolism

Disease and Treatment-Related Burden in Patients With Acromegaly Who Are Biochemically Controlled on Injectable Somatostatin Receptor Ligands

Maria Fleseriu et al.

Summary: This study examined the burden associated with SRL injections in acromegaly patients who have achieved biochemical control. Despite being biochemically controlled, patients commonly reported experiencing symptoms that interfere with daily life and work, along with gastrointestinal side effects and injection site reactions. This highlights the significant disease burden that still persists for these patients.

FRONTIERS IN ENDOCRINOLOGY (2021)

Article Medicine, General & Internal

Self-Administration of Long-Acting Somatostatin Analogues in NET Patients-Does It Affect the Clinical Outcome?

Anna Sowa-Staszczak et al.

Summary: This study aimed to compare the impact of different administration routes (injection performed by professional medical staff vs. self-injection) of long-acting somatostatin analogues (SSA) on progression-free survival in patients with neuroendocrine tumors (NETs). The results showed a slightly higher rate of NET progression in the self-injection group compared to the group with injections performed by professional medical staff.

MEDICINA-LITHUANIA (2021)

Article Endocrinology & Metabolism

Benefits of a nurse-led home injection service for acromegaly patients treated with somatuline autogel

Amit Akirov et al.

Summary: The nurse-led home injection service for somatuline autogel injections is associated with high adherence to treatment among acromegaly patients. Establishing such a program globally may lead to better adherence to treatment and improved disease control, especially for patients with biochemically controlled acromegaly.

ENDOCRINE (2021)

Review Endocrinology & Metabolism

Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms

Johannes Hofland et al.

ENDOCRINE REVIEWS (2020)

Review Biochemistry & Molecular Biology

Somatostatin Analogs in Clinical Practice: A Review

Mariana Gomes-Porras et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Oncology

Delays and routes to diagnosis of neuroendocrine tumours

Ron Basuroy et al.

BMC CANCER (2018)

Article Health Care Sciences & Services

Budget impact of somatostatin analogs as treatment for metastatic gastroenteropancreatic neuroendocrine tumors in US hospitals

Jesse D. Ortendahl et al.

CLINICOECONOMICS AND OUTCOMES RESEARCH (2017)

Review Medicine, General & Internal

Principles of diagnosis and management of neuroendocrine tumours

Michael J. Raphael et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2017)

Review Chemistry, Medicinal

Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumors

Rosa Maria Paragliola et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2016)

Review Psychology, Clinical

The influence of cognition on self-management of type 2 diabetes in older people

Ali Tomlin et al.

PSYCHOLOGY RESEARCH AND BEHAVIOR MANAGEMENT (2016)

Article Critical Care Medicine

Shared Treatment Decision Making Improves Adherence and Outcomes in Poorly Controlled Asthma

Sandra R. Wilson et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)

Review Genetics & Heredity

Acromegaly

Philippe Chanson et al.

ORPHANET JOURNAL OF RARE DISEASES (2008)

Article Rheumatology

Treatment choices, preferences and decision-making by patients with rheumatoid arthritis

Frances Chilton et al.

MUSCULOSKELETAL CARE (2008)